Pathology and prevention of Leucocytozoon smithi infection of Turkeys.
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D016782:Apicomplexa / Q000302:isolation & purification; D001593:Benzyl Compounds / Q000627:therapeutic use; D001769:Blood / Q000382:microbiology; D003622:Dapsone / Q000627:therapeutic use; D004175:Diptera; D008738:Methyl Ethers / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000627:therapeutic use; D011201:Poultry Diseases / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control; D011528:Protozoan Infections / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control; D011529:Protozoan Infections, Animal; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D013154:Spleen / Q000473:pathology; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D014422:Turkeys
D000981:Antiprotozoal Agents; D001593:Benzyl Compounds; D008738:Methyl Ethers; D009593:Nitroimidazoles; D011725:Pyridines; D011743:Pyrimidines; D011810:Quinoxalines; D013424:Sulfanilamides; D013412:Sulfadimethoxine; D003622:Dapsone